Pluvicto 1,000 MBq/mL (27 mCi/mL) injection Images
Generic Name: lutetium lu 177 vipivotide tetraxetan
This medication has been identified as Pluvicto 1,000 MBq/mL (27 mCi/mL) injection. It is supplied by Advanced Accelerator Applications USA, Inc.
Pluvicto is used in the treatment of Prostate Cancer and belongs to the drug class therapeutic radiopharmaceuticals. Pluvicto 1,000 MBq/mL (27 mCi/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Pluvicto
- Generic Name
- lutetium lu 177 vipivotide tetraxetan
- Strength
- 1,000 MBq/mL (27 mCi/mL) injection
- Availability
- Prescription only
- Drug Class
- Therapeutic radiopharmaceuticals
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Advanced Accelerator Applications USA, Inc.
- Manufacturer
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 69488-0010
More about Pluvicto (lutetium lu 177 vipivotide tetraxetan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: therapeutic radiopharmaceuticals
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
